Richard A. Larson to NK Cell Lectin-Like Receptor Subfamily K
This is a "connection" page, showing publications Richard A. Larson has written about NK Cell Lectin-Like Receptor Subfamily K.
Connection Strength
0.013
-
Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: Cancer and Leukemia Group B study 9420. Clin Cancer Res. 2002 Sep; 8(9):2812-9.
Score: 0.013